Gelesis, Inc. Receives $16,000,000 Series A Funding Round

  • Feed Type
  • Date
    1/3/2008
  • Company Name
    Gelesis, Inc.
  • Mailing Address
    222 Berkeley St Boston, MA 02116
  • Company Description
    Gelesis is a Research and Development company for the treatment of obesity.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $16,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    OrbiMed
  • Venture Investor
    OrbiMed
  • Venture Investor
    PureTech Ventures
  • Venture Investor
    Queensland Investment Corporation

Trending on Xconomy